Cancer incidence outcomes included in the new CONFIDENCE software.
|Cancer groupings applied and source of additive and multiplicative excess risk to dose response models||Organ dose type required|
|All solid cancers (ICD10:C00-C80)
Japanese A-bomb Life Span Study (LSS)
Cohort:1958–2009 (Grant et al., 2017)
|All leukemia (ICD10:C91-C95), excluding CLL (ICD10:C91.1, C91.4) and ATL (ICD10:C91.5)
LSS cohort:1958–2001 (Hsu et al., 2013)
|Red bone marrow|
|Thyroid cancer (ICD10:C73)
LSS cohort:1958–1999 (Jacob et al., 2014)
|Female breast cancer (ICD10:C50)
Pooled study of eight cohorts (Preston et al., 2002)
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.